We were part of the Heart Failure Association Conference of the Polish Cardiac Society in Kraków.

The Seerlinq team had a great time at the Heart Failure 2026 congress in Barcelona!

We’re proud that Seerlinq was part of the second edition of the AdvanceMed CZ 2026 conference in Ostrava.

Seerlinq took part in LSI USA ’26 – one of the most important partnering events in medtech.

Eight days in Manhattan. An intensive accelerator program. A proud moment for Seerlinq.

ITAPA recognizes initiatives that drive Slovakia forward through digitalization, innovation and technological progress.

November didn’t slow down for a second for the Seerlinq team. In the space of one week, we joined four major global events.

On World Heart Day, we’re reminded why we do what we do – bringing better heart care to patients everywhere.

It is a great honor for us that the Seerlinq® technology was presented at the ESC 2025 Congress in Madrid.

Seerlinq’s non-invasive technology was validated after 6 months of telemonitoring and presented in the ESC Late-Breaking Science session.

We are proud to announce that Seerlinq HeartCore is now a certified Class II(b) medical device under the EU MDR 2017/745 regulation.

More than 200 patients have already joined our program, and we’re working with over 50 psychicians across Slovakia!

Seerlinq is proud to have been recognized in the Deloitte Technology Fast 50 CE 2024, celebrating our innovation in healthcare!

We are continuously working on our research to improve the quality of our technologies.

Seerlinq Has an International Reach!

Our Patients’ First Year Without Hospitalization!

Our network of patients and specialists is continually growing!

Seerlinq is now covered by all health insurance companies in Slovakia.

We Are Now Available to All Heart Failure Patients in Slovakia.

We’ve launched our first product for heart failure patients in Slovakia, a significant step forward in our mission!

Seerlinq presented at the largest heart failure conference in the world, held in Lisbon.

Two cases were accepted for oral presentation at ESC congresses!